Recent News

• 12.08.2025 - Karyopharm to Participate in Baird's Biotech Discovery Series
• 12.01.2025 - Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 12.01.2025 - Karyopharm to Participate at the Piper Sandler 37th Annual Healthcare Conference
• 11.03.2025 - Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 11.03.2025 - Karyopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress
• 10.27.2025 - Karyopharm to Report Third Quarter 2025 Financial Results on November 3, 2025

Recent Filings

• 11.24.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 11.24.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.03.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.03.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.03.2025 - S-3 Registration statement under Securities Act of 1933
• 11.03.2025 - 8-K Current report
• 11.03.2025 - EX-99.1 EX-99.1
• 11.03.2025 - S-3 Registration statement under Securities Act of 1933